The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/161331
Pharma Manufacturing companyÕs commitment to thwart the effects of counterfeiters and to demonstrate such commitment through regular and open communications on the topic. Anticounterfeiting measures may not immediately have a positive business case, and for many associates, it is difficult to see the benefits of the effort at all. Support from top management is crucial to signal that the problem must be addressed proactively and that associates who are empowered to implement anticounterfeiting measures are contributing to the wealth of the company. Without explicit executive acknowledgement of a strong case for action, typically rooted in consumer safety, brand equity, and business value, brand protection commitments inside the supply chain will become fragmented, ineffective, inconsistent, and financially challenged and will eventually lead to unmitigated risks. Control Credo® precision packaging and comprehensive asset management solutions ensure your temperature-controlled payload reaches its destination safely. per·for·mance 1RXQSκU I{UPκQV The act of performing; carrying into execution or action; achievement; accomplishment; representation by action; as, a thing done or carried through; an achievement; a deed; an act; a feat; extended duration lower cost of ownership quick assembly 100% recyclable NCUVOKNGRGCEGQHOKPF ease of use elimination of excursions high payload volume ratio accurate & consistent ƃ GZKDNGOQFWNCTFGUKIP greater return on investment PROVEN. PRECISE. RELIABLE. (877) 537.9800 | www.mnthermalscience.com © 2013 Minnesota Thermal Science 38 LifeScienceLeader.com September 2013 Governance and Policy Stewardship. Because counterfeit trade can engulf virtually every function in the organization, cross-functional oversight and governance of policies, positions, and practices are vital to the effectiveness and sustainability of the companyÕs brand protection efforts. Typically, pharmaceuticals organizations will set policies and procedures pertaining to IP protection through close collaboration among the law department, including trademark and patent attorneys, quality & compliance officers, government affairs, the security department, and business unit heads. This internal governing body, composed of proven leaders, can guide and inform senior executives on strategic brand protection issues, political and regulatory direction, and important events. This standing committee (council) will create and maintain internal policies and mandates pertaining to the broad issues of protecting the supply chain. It is also important for the company to have a consistent ÒvoiceÓ to external partners and the public, relative to its practices. Such a council is invaluable in communicating such positions throughout internal and external communications networks. Brand Protection Expertise. As a business discipline, brand protection is a nascent function for most organizations. It is important to design, fund, and manage brand protection activities as an operational unit for the purpose of providing subject-matter expertise for the long term. The core mission of the brand protection group is to assess risk, develop and advise on the implementation of counter measures, and develop the tools needed to protect the company and its customers from false versions of its brands.